About Bioxydyn
Bioxydyn is a company based in Manchester (United Kingdom) founded in 2009.. Bioxydyn has raised $1.93 million across 1 funding round from investors including The North West Fund and MTI Partners. The company has 8 employees as of December 31, 2021. Bioxydyn offers products and services including Quantitative Imaging Services, Respiratory Imaging, Cancer Imaging, Inflammation Imaging, and Neuroimaging Services. Bioxydyn operates in a competitive market with competitors including Polarean Imaging, Tomophase, Fluidda, Cyclopharm and Elaatech, among others.
- Headquarter Manchester, United Kingdom
- Employees 8 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioxydyn Limited
- Date of Incorporation 05 Mar, 2009
- Jurisdiction MANCHESTER, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.93 M (USD)
in 1 rounds
-
Latest Funding Round
$1.93 M (USD), Series A
Oct 04, 2012
-
Investors
The North West Fund
& 1 more
-
Employee Count
8
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioxydyn
Bioxydyn offers a comprehensive portfolio of products and services, including Quantitative Imaging Services, Respiratory Imaging, Cancer Imaging, Inflammation Imaging, and Neuroimaging Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers MRI-based biomarkers for assessing disease and drug effects in research.
Offers MRI methods for evaluating lung function in respiratory diseases.
Provides functional MRI biomarkers to inform tumor therapy effectiveness.
Uses quantitative MRI for studying inflammation in various diseases.
Applies MRI techniques for conditions like multiple sclerosis and dementia.
Measures liver function using dynamic contrast-enhanced MRI methods.
Funding Insights of Bioxydyn
Bioxydyn has successfully raised a total of $1.93M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.93 million completed in October 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $1.9M
-
First Round
First Round
(04 Oct 2012)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2012 | Amount | Series A - Bioxydyn | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bioxydyn
Bioxydyn has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include The North West Fund and MTI Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bioxydyn
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bioxydyn
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioxydyn Comparisons
Competitors of Bioxydyn
Bioxydyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Polarean Imaging, Tomophase, Fluidda, Cyclopharm and Elaatech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Noble gas polarizers for hyperpolarized pulmonary MRI are developed.
|
|
| domain | founded_year | HQ Location |
Endoscopic devices for respiratory disorders are developed using optical interferometry.
|
|
| domain | founded_year | HQ Location |
Functional respiratory imaging and contract research services are provided.
|
|
| domain | founded_year | HQ Location |
Medical devices and radiopharmaceuticals for lung imaging are developed.
|
|
| domain | founded_year | HQ Location |
Provider of software for lung cancer diagnosis
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Bioxydyn
When was Bioxydyn founded?
Bioxydyn was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Where is Bioxydyn located?
Bioxydyn is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Is Bioxydyn a funded company?
Bioxydyn is a funded company, having raised a total of $1.93M across 1 funding round to date. The company's 1st funding round was a Series A of $1.93M, raised on Oct 04, 2012.
How many employees does Bioxydyn have?
As of Dec 31, 2021, the latest employee count at Bioxydyn is 8.
What does Bioxydyn do?
Founded in 2009 and based in Manchester, United Kingdom, BiOxyDyn operates in the medical imaging sector, focusing on tools for respiratory conditions like COPD and asthma. Imaging services, including oxygen-enhanced MRI for lung oxygenation, dynamic contrast-enhanced MRI for perfusion analysis, and diffusion MRI for tissue structure assessment, are provided. A combined package named Pulmolux targets respiratory disorders. As a contract research organization, clinical diagnostic solutions are being developed.
Who are the top competitors of Bioxydyn?
Bioxydyn's top competitors include Fluidda, Polarean Imaging and Tomophase.
What products or services does Bioxydyn offer?
Bioxydyn offers Quantitative Imaging Services, Respiratory Imaging, Cancer Imaging, Inflammation Imaging, and 2 more products and services.
Who are Bioxydyn's investors?
Bioxydyn has 2 investors. Key investors include The North West Fund, and MTI Partners.